A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome

Published:2023-05-01 Issue:9 Volume:62 Page:1329-1334
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Goto Hideaki¹,Yakushijin Kimikazu¹,Adachi Yoko²,Matsumoto Hisayuki³,Yamamoto Katsuya¹,Matsumoto Sakuya¹,Yamashita Tomoe³,Higashime Ako¹,Kawaguchi Koji¹,Kurata Keiji¹,Matsuoka Hiroshi¹,Minami Hironobu¹

Affiliation:

1. Department of Medical Oncology and Hematology, Kobe University Hospital, Japan

2. Department of Internal Medicine, JCHO Kobe Central Hospital, Japan

3. Department of Clinical Laboratory, Kobe University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/9/62_0174-22/_pdf

Reference20 articles.

1. 1. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. The PML-RAR alpha fusion mRNA generated by the t (15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675-684, 1991.

2. 2. Sanz MA, Fenaux P, Tallman MS, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133: 1630-1643, 2019.

3. 3. Grimwade D, Biondi A, Mozziconacci MJ, et al.; Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96: 1297-1308, 2000.

4. 4. Welch JS, Westervelt P, Ding L, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 305: 1577-1584, 2011.

5. 5. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 89: 376-387, 1997.